腺相关病毒引发了相应疾病。
Adeno-associated virus finds its disease.
作者信息
Russell David W, Grompe Markus
机构信息
Departments of Medicine and Biochemistry, University of Washington, Seattle, Washington, USA.
Papé Family Pediatric Research Institute, Oregon Health and Science University, Portland, Oregon, USA.
出版信息
Nat Genet. 2015 Oct;47(10):1104-5. doi: 10.1038/ng.3407.
Abstract
Adeno-associated virus (AAV) vectors have been widely adopted for use in gene therapy. A new study raises concerns regarding this approach, reporting that chromosomal insertions of AAV serotype 2 seem to activate proto-oncogenes in human hepatocellular carcinoma.
摘要
腺相关病毒（AAV）载体已被广泛应用于基因治疗。一项新的研究引发了对这种方法的担忧，该研究报告称，2型腺相关病毒血清型的染色体插入似乎会激活人类肝细胞癌中的原癌基因。
相似文献
1
Adeno-associated virus finds its disease.腺相关病毒引发了相应疾病。
Nat Genet. 2015 Oct;47(10):1104-5. doi: 10.1038/ng.3407.
2
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?2型腺相关病毒与肝细胞癌？
Hum Gene Ther. 2015 Dec;26(12):779-81. doi: 10.1089/hum.2015.29014.kib.
3
AAV vector integration sites in mouse hepatocellular carcinoma.小鼠肝细胞癌中的腺相关病毒载体整合位点
Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.
4
AAV2 and Hepatocellular Carcinoma.腺相关病毒2型与肝细胞癌
Hum Gene Ther. 2016 Mar;27(3):211-3. doi: 10.1089/hum.2016.002.
5
Assessing the potential for AAV vector genotoxicity in a murine model.评估 AAV 载体在小鼠模型中的潜在遗传毒性。
Blood. 2011 Mar 24;117(12):3311-9. doi: 10.1182/blood-2010-08-302729. Epub 2010 Nov 24.
6
High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors.重组腺相关病毒3型载体对肝癌细胞的高效转导
J Vis Exp. 2011 Mar 22(49):2538. doi: 10.3791/2538.
7
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.人类肝细胞癌中反复出现的 AAV2 相关插入性突变。
Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.
8
AAV Infection: Protection from Cancer.腺相关病毒感染：预防癌症。
Hum Gene Ther. 2017 Apr;28(4):323-327. doi: 10.1089/hum.2016.147. Epub 2016 Nov 10.
9
Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.寻找并摧毁：用于将基因递送至肝细胞癌的靶向腺相关病毒
Drug Deliv. 2017 Nov;24(1):289-299. doi: 10.1080/10717544.2016.1247926.
10
Adeno-associated virus infection and its impact in human health: an overview.腺相关病毒感染及其对人类健康的影响：概述。
Virol J. 2022 Oct 31;19(1):173. doi: 10.1186/s12985-022-01900-4.
引用本文的文献
1
Nonviral targeted mRNA delivery: principles, progresses, and challenges.非病毒靶向mRNA递送：原理、进展与挑战。
MedComm (2020). 2025 Jan 2;6(1):e70035. doi: 10.1002/mco2.70035. eCollection 2025 Jan.
2
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus.新出现的数据影响了使用重组腺相关病毒进行血友病基因治疗的风险/效益评估。
Front Med (Lausanne). 2023 Nov 10;10:1256919. doi: 10.3389/fmed.2023.1256919. eCollection 2023.
3
Liver directed adeno-associated viral vectors to treat metabolic disease.肝脏靶向腺相关病毒载体治疗代谢性疾病。
J Inherit Metab Dis. 2024 Jan;47(1):22-40. doi: 10.1002/jimd.12637. Epub 2023 Jun 5.
4
Cell and gene therapy for kidney disease.肾脏疾病的细胞和基因治疗。
Nat Rev Nephrol. 2023 Jul;19(7):451-462. doi: 10.1038/s41581-023-00702-3. Epub 2023 Mar 27.
5
Recent Advances in Lipid Nanoparticles for Delivery of mRNA.用于递送mRNA的脂质纳米颗粒的最新进展
Pharmaceutics. 2022 Dec 1;14(12):2682. doi: 10.3390/pharmaceutics14122682.
6
Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges.用于基因治疗的病毒载体系统：进展与生物安全挑战的综合文献综述
Appl Biosaf. 2020 Mar 1;25(1):7-18. doi: 10.1177/1535676019899502.
7
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.评估腺相关病毒整合的科学现状：综合视角。
Mol Ther. 2022 Aug 3;30(8):2646-2663. doi: 10.1016/j.ymthe.2022.06.004. Epub 2022 Jun 10.
8
Cryo-electron Microscopy of Adeno-associated Virus.腺相关病毒的冷冻电子显微镜观察
Chem Rev. 2022 Sep 14;122(17):14018-14054. doi: 10.1021/acs.chemrev.1c00936. Epub 2022 May 16.
9
Gene Therapy for Duchenne Muscular Dystrophy.杜氏肌营养不良症的基因治疗。
J Neuromuscul Dis. 2021;8(s2):S303-S316. doi: 10.3233/JND-210678.
10
AAV integration in human hepatocytes.AAV 在人肝细胞中的整合。
Mol Ther. 2021 Oct 6;29(10):2898-2909. doi: 10.1016/j.ymthe.2021.08.031. Epub 2021 Aug 28.
本文引用的文献
1
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.人类肝细胞癌中反复出现的 AAV2 相关插入性突变。
Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.
2
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.载体设计影响腺相关病毒基因治疗后的肝脏遗传毒性。
J Clin Invest. 2015 Feb;125(2):870-80. doi: 10.1172/JCI79213. Epub 2015 Jan 20.
3
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.非酒精性脂肪性肝炎——肝细胞癌发生的前驱病变
World J Gastroenterol. 2014 Nov 28;20(44):16464-73. doi: 10.3748/wjg.v20.i44.16464.
4
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.无核酸酶的无启动子基因靶向改善小鼠乙型血友病
Nature. 2015 Jan 15;517(7534):360-4. doi: 10.1038/nature13864. Epub 2014 Oct 29.
5
Emerging trends in hepatocellular carcinoma incidence and mortality.肝细胞癌发病率和死亡率的新趋势。
Hepatology. 2015 Jan;61(1):191-9. doi: 10.1002/hep.27388. Epub 2014 Nov 24.
6
Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesis.鉴定 rtl1 为一种新型肝癌发生的反转录转座子衍生的印记基因驱动子。
PLoS Genet. 2013 Apr;9(4):e1003441. doi: 10.1371/journal.pgen.1003441. Epub 2013 Apr 4.
7
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.慢病毒载体插入突变鉴定与肝癌相关的基因。
Nat Methods. 2013 Feb;10(2):155-61. doi: 10.1038/nmeth.2331. Epub 2013 Jan 13.
8
Induction of hepatocellular carcinoma by in vivo gene targeting.体内基因靶向诱导肝细胞癌。
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11264-9. doi: 10.1073/pnas.1117032109. Epub 2012 Jun 25.
9
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.全基因组范围内检测肝细胞癌中 HBV 的反复整合。
Nat Genet. 2012 May 27;44(7):765-9. doi: 10.1038/ng.2295.
10
Adeno-associated virus biology.腺相关病毒生物学
Methods Mol Biol. 2011;807:1-23. doi: 10.1007/978-1-61779-370-7_1.
Zotero 插件